hepatitis c

Every year on July 28, the world comes together to raise awareness of an infectious disease that affects so many. It’s world hepatitis day. It is a time was patient organizations, governments, medical professionals, and the general public to educate others about this viral disease. Viral hepatitis is one of the leading causes of death ...click here to read more

Hepatitis C virus (HCV) infection has been found to cause rheumatoid arthritis (RA), even before HCV is detected. Hepatitis C can contribute to liver failure, but is also known to cause rheumatoid arthritis – inflammation of the joints. Due to the link between HCV and rheumatoid conditions, it’s important that newly diagnosed RA patients get ...click here to read more

Hepatitis C infection in liver cirrhosis patients can be cured with investigational oral therapy. An advanced form of liver disease, cirrhosis can be caused by hepatitis C infection, alcoholism, autoimmune disease, and other strains of hepatitis, among other causes. Hepatitis C attacks the liver, leading to the formation of scar tissue. In its early stages, ...click here to read more

Hepatitis C screening is recommended for baby boomers as they face higher viral infection risk. Those who were born between 1945 and 1965 – baby boomers – have a five times greater risk of having been exposed to hepatitis C infection. For this reason, the CDC Task Force has recommended that those born during that ...click here to read more

Zika virus development can be slowed down by experimental hepatitis C antiviral drug. Professor Johan Neyts explained, “The Zika virus is transmitted by the tiger mosquito. Roughly twenty percent of the people who are infected actually get sick. The most common symptoms, which last about a week, are fever, fatigue, joint and muscle pain, rash, ...click here to read more

May is Hepatitis Awareness Month, which mainly focuses on the different types of hepatitis including hepatitis C, but we have compiled a list of our news stories discussing hepatitis alongside other conditions like Parkinson’s disease, rheumatoid arthritis, and liver inflammation. Hepatitis B and C are lifelong conditions that increase your risk of health complications, including ...click here to read more

The Centers for Disease Control and Prevention (CDC) have reported 19 hepatitis C cases in 19 dialysis clinics. There were 36 cases of hepatitis C between 2014 and 2015 in 19 dialysis clinics, and nine of those cases were transmitted person-to-person. They report that lapses in infection control procedures are to blame for the rise ...click here to read more

A new study has found that hepatitis C may increase the risk of Parkinson’s disease. Parkinson’s disease is a neurological degenerative brain disorder and hepatitis C is a virus which negatively impacts the liver. Study author Chia-Hung Kao said, “Many factors clearly play a role in the development of Parkinson’s disease, including environmental factors. This ...click here to read more

Hepatitis C virus (HCV) infection has been found to cause rheumatoid arthritis, even before HCV is detected. Hepatitis C can contribute to liver failure but is also known to cause rheumatoid arthritis – inflammation of the joints. Due to the link between HCV and rheumatoid conditions, it’s important that newly diagnosed patients of rheumatoid conditions ...click here to read more

Yale researchers have found that novel antiviral therapies for hepatitis C could reduce the prevalence of the virus by 80 percent. The findings suggest that hepatitis C virus (HCV) could be eliminated within the U.S. if screening becomes enhanced and treatment is targeted to high-risk populations. Direct-acting antiviral medications have been recently approved for hepatitis ...click here to read more

A new study has found that a combination therapy of antiviral medications can be successful in treating hepatitis C in patients with advanced liver disease. Co-principal investigator Michael Curry, M.D., said, “More than half of the patients in the study had failed a prior course of treatment for hepatitis C infection. Our trial showed that ...click here to read more

A new study shows that nearly half of Medicaid patients requiring a cutting-edge hepatitis C drug have been denied due to tight controls from states as well as the high cost of the drugs. Roughly 46 percent of Medicaid patients were denied the new hepatitis C drug that could greatly improve their condition, possible even ...click here to read more